Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 197 blog entries.

December 2024 Price Concessions 3rd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2024) announced the following list of price concessions for December 2024: Drug Pack size Price concession Alendronic acid 70mg/100ml oral solution unit dose sugar free 4 £28.78 Alfuzosin [...]

The post December 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

By |December 20th, 2024|Lexpos News|Comments Off on December 2024 Price Concessions 3rd Update

Three new SSPs issued for Estradot® patches

In response to a significant ongoing disruption to the supply of some strengths of Estradot® patches, three Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 19th December 2024, SSP079, provides that for every Estradot® 50micrograms/24hours patch originally prescribed either one Evorel® 50 patch or one [...]

The post Three new SSPs issued for Estradot® patches appeared first on Community Pharmacy England.

By |December 19th, 2024|Lexpos News|Comments Off on Three new SSPs issued for Estradot® patches

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV)

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) Drug alert number: EL (24)A/63 Date issued: 19 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Vyvgart 1000 mg solution for injection (Argenx BV) DMRC reference number: DMRC-34131563 Company name:Argenx [...]

The post MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) appeared first on Community Pharmacy England.

By |December 19th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV)

MHRA Drug Safety Update: December 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 5 December 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in November 2024 To see th...

By |December 12th, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: December 2024

Two SSPs issued for Cefalexin oral suspension sugar free

In response to a significant ongoing disruption to the supply of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free, two Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 10 December 2024, SSP077 provides that for every 5 ml of Cefalexin 125mg/5ml [...]

The post Two SSPs issued for Cefalexin oral suspension sugar free appeared first on Community Pharmacy England.

By |December 10th, 2024|Lexpos News|Comments Off on Two SSPs issued for Cefalexin oral suspension sugar free